Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Receivables (2023 - 2025)

WORK Medical Technology filings provide 3 years of Receivables readings, the most recent being $2.1 million for Q3 2025.

  • On a quarterly basis, Receivables rose 2.05% to $2.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 2.05% increase, with the full-year FY2025 number at $2.1 million, up 2.05% from a year prior.
  • Receivables hit $2.1 million in Q3 2025 for WORK Medical Technology, down from $2.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $7.6 million in Q3 2023 to a low of $2.0 million in Q3 2024.
  • Median Receivables over the past 3 years was $2.2 million (2025), compared with a mean of $3.5 million.
  • Biggest five-year swings in Receivables: crashed 72.94% in 2024 and later rose 2.05% in 2025.
  • WORK Medical Technology's Receivables stood at $7.6 million in 2023, then crashed by 72.94% to $2.0 million in 2024, then increased by 2.05% to $2.1 million in 2025.
  • The last three reported values for Receivables were $2.1 million (Q3 2025), $2.3 million (Q1 2025), and $2.0 million (Q3 2024) per Business Quant data.